Skip to main content
Caplight Logo









Sinfonia Biotherapeutics

Sinfonia Biotherapeutics

Private
HuddingeHealthcare & Life Scienceshttps://sinfoniabiotherapeutics.com

Last Round

Grant

Dec 1, 2018

Total Funding Raised

$555,000

Company Overview

Sinfonia Biotherapeutics is a biotechnology company that develops next-generation biotherapeutics for patients suffering from pain and neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

gene therapyencapsulated cell biodeliverycell therapyneurological disordersclinical stage biotechbiodelivery platformCNS drug deliveryneurodegenerationrare disease therapybiologicsdrug delivery deviceadvanced therapy medicinal productsATMPimplantable drug deliveryParkinson's diseasefrontotemporal dementianeuropathic painpharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sinfonia Biotherapeutics Comparables

Compare Sinfonia Biotherapeutics with similar companies based on industry and business-model similarity.

Sinfonia Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AviadoBio
77%
CombiGene AB
76%
Spur Therapeutics
75%

Sinfonia Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 1, 2018
GrantNov 1, 2017

Sinfonia Biotherapeutics Investors

Notable investors and investment history

Sinfonia Biotherapeutics investors
InvestorRounds
European CommissionGrant
VinnovaGrant
The Michael J. Fox Foundation for Parkinson's ResearchGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2018

    $59K grant received from the European Commission.

Sinfonia Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sinfonia Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sinfonia Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHuddinge
Employee Range1
Year Founded2017
Last FundingDec 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?